BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Leukocyte
,
Nosology
,
Fenofibrate
,
rs6983267
,
MYC
,
T cell receptor signaling pathway
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
proto- oncogene c- bcl- 2
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for proto- oncogene c- bcl- 2
Explore Curated Studies Results
Literature
Most Relevant Literature
Evaluation of Bax and BCL 2 Genes Polymorphisms in Iraqi Women with Breast Cancer.
Expression of miR-195 and its target gene Bcl-2 in human intervertebral disc degeneration and their …
Use of cellular exosomes as a new carrier in breast cancer gene therapy.
Clinical course and features of persistent polyclonal B-cell lymphocytosis with BCL-6 amplification …
Lack of GCN5 remarkably enhances the resistance against prolonged endoplasmic reticulum stress-induc…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation
Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly…
An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg
Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia
Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leu…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ